A detailed history of Norwood Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Norwood Financial Corp holds 150 shares of AMGN stock, worth $39,477. This represents 0.06% of its overall portfolio holdings.

Number of Shares
150
Previous 125 20.0%
Holding current value
$39,477
Previous $36,000 16.67%
% of portfolio
0.06%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $6,721 - $8,114
25 Added 20.0%
150 $42,000
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $24,860 - $28,450
125 New
125 $28,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.